Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 2929381, 6 pages
https://doi.org/10.1155/2017/2929381
Research Article

Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma

1Department of Laboratory Medicine, Hangzhou First People’s Hospital, Hangzhou, Zhejiang 310006, China
2Hangzhou Cancer Institution, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, China

Correspondence should be addressed to Yueming Chen; moc.361@2791ylwmyc

Received 15 March 2017; Accepted 4 July 2017; Published 29 August 2017

Academic Editor: Paola Gazzaniga

Copyright © 2017 Xueyan Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Fung and A. S. Lok, “Management of patients with hepatitis B virus-induced cirrhosis,” Journal of Hepatology, vol. 42, no. 1, pp. S54–S64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Tanaka, F. Katayama, H. Kato et al., “Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures,” Journal of Epidemiology, vol. 21, no. 6, pp. 401–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Tischoff and A. Tannapfel, “DNA methylation in hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 14, no. 11, pp. 1741–1748, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Y. Park, B. H. Sohn, E. Yu et al., “Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein,” Gastroenterology, vol. 132, no. 4, pp. 1476–1494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Lim, S. H. Park, and K. L. Jang, “Hepatitis C virus core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation,” Cancer Letters, vol. 321, no. 2, pp. 154–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Nagashio, E. Aral, H. Ojima, T. Kosuge, Y. Kondo, and Y. Kanai, “Carcinogenic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage,” International Journal of Cancer, vol. 129, no. 5, pp. 1170–1179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Leon, B. Shapiro, D. M. Sklaroff, and M. J. Yaros, “Free DNA in the serum of cancer patients and the effect of therapy,” Cancer Research, vol. 37, no. 3, pp. 646–650, 1977. View at Google Scholar
  8. D. E. Matei and K. P. Nephew, “Epigenetic therapies for chemoresensitization of epithelial ovarian cancer,” Gynecologic Oncology, vol. 116, no. 2, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. V. V. Levenson and A. A. Melnikov, “DNA methylation as clinically useful biomarkers - light at the end of the tunnel,” Pharmaceuticals, vol. 5, no. 1, pp. 94–113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Jung, M. Fleischhacker, and A. Rabien, “Cell-free DNA in the blood as a solid tumor biomarker: a critical appraisal of the literature,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1611–1624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Dulaimi, J. Hillinck, I. Ibanez de Caceres, T. Al-Saleem, and P. Cairns, “Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients,” Clinical Cancer Research, vol. 10, no. 18, Part 1, pp. 6189–6193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Simmer, A. B. Brinkman, Y. Assenov et al., “Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues,” Epigenetics, vol. 7, no. 12, pp. 1355–1367, 2012. View at Publisher · View at Google Scholar
  13. P. Han, Y. Fu, J. Liu et al., “Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma,” American Journal of Cancer Research, vol. 5, no. 4, pp. 1396–1409, 2015. View at Google Scholar
  14. I. Guilleret, L. Losi, S. T. Chelbi et al., “DNA methylation profiling of esophageal adenocarcinoma using methylation ligation-dependent macroarray (MLM),” Biochemical and Biophysical Research Communications, vol. 479, no. 2, pp. 231–237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. C. C. Kuo, C. Y. Lin, Y. L. Shih et al., “Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 8, pp. 1235–1245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Campan, D. J. Weisenberger, B. Trinh, and P. W. Laird, “MethyLight,” Methods in Molecular Biology, vol. 507, pp. 325–337, 2009. View at Publisher · View at Google Scholar
  17. M. J. Fackler, M. McVeigh, J. Mehrotra et al., “Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer,” Cancer Research, vol. 64, no. 13, pp. 4442–4452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Fujita, N. Kagara, N. Yamamoto et al., “Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis,” Oncology Letters, vol. 8, no. 1, pp. 397–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Zopf, M. Ocker, D. Neureiter et al., “Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines,” BMC Cancer, vol. 12, p. 386, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Feng, S. E. Hawes, J. E. Stern et al., “DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients,” Cancer Epidemiology, Biomarkers & Prevention, vol. 17, no. 3, pp. 645–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Hayashi, G. Wu, J. L. Roh et al., “Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma,” Cancer, vol. 121, no. 12, pp. 1957–1965, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Zhang, S. Liu, Z. Zhang et al., “Analysis of BRAFV600E mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies,” Diagnostic Pathology, vol. 9, p. 45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. A. Eads, K. D. Danenberg, K. Kawakami et al., “MethyLight: a high-throughput assay to measure DNA methylation,” Nucleic Acids Research, vol. 28, article E32, 2000. View at Publisher · View at Google Scholar
  24. C. A. Eads, R. V. Lord, K. Wickramasinghe et al., “Epigenetic patterns in the progression of esophageal adenocarcinoma,” Cancer Research, vol. 61, no. 8, pp. 3410–3418, 2001. View at Google Scholar
  25. S. Ogino, T. Kawasaki, M. Brahmandam et al., “Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis,” The Journal of Molecular Diagnostics, vol. 8, no. 2, pp. 209–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. W. B. Coleman and A. G. Rivenbark, “Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease,” The Journal of Molecular Diagnostics, vol. 8, no. 2, pp. 152–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. H. Zhao, Y. C. Fan, Y. Yang, and K. Wang, “Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis,” World Journal of Gastroenterology, vol. 19, no. 41, pp. 7189–7196, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Y. Lu, S. Y. Chen, H. L. Peng, P. Y. Kan, W. C. Chang, and C. J. Yen, “Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma,” Oncotarget, vol. 8, no. 4, pp. 6406–6418, 2017. View at Publisher · View at Google Scholar
  29. Z. H. Huang, Y. Hu, D. Hua, Y. Y. Wu, M. X. Song, and Z. H. Cheng, “Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma,” Experimental and Molecular Pathology, vol. 91, no. 3, pp. 702–707, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ogino, A. T. Chan, C. S. Fuchs, and E. Giovannucci, “Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field,” Gut, vol. 60, no. 3, pp. 397–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Y. Huang, J. G. Yao, B. C. Huang, Y. Ma, Q. Xia, and X. D. Long, “Polymorphisms of a disintegrin and metalloproteinase with thrombospondin motifs 5 and aflatoxin B1-related hepatocellular carcinoma,” Cancer Epidemiology, Biomarkers & Prevention, vol. 25, no. 2, pp. 334–343, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Ogino, R. Nishihara, T. J. VanderWeele et al., “The role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic disease in the era of precision medicine,” Epidemiology, vol. 27, no. 4, pp. 602–611, 2016. View at Publisher · View at Google Scholar · View at Scopus